Evidence map›Paper›PMID 40903536›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2025

Current status of the use of validated home blood pressure monitoring devices among Korean patients with hypertension.

Jieun Lee, Yu-Mi Kim, Seungwon Yoo, Dae-Young Kim, Sung-Hee Shin, Jin Oh Na, Jinho Shin, Kiho Park, Eun Mi Lee

Abstract read
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jieun LeeDivision of Cardiology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Yu-Mi KimDepartment of Preventive Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
Seungwon YooMirabellsoft Co., Ltd., Seoul, Republic of Korea.
Dae-Young KimDivision of Cardiology, Department of Internal Medicine, Inha University Hospital, Incheon, Republic of Korea.
Sung-Hee ShinDivision of Cardiology, Department of Internal Medicine, Inha University Hospital, Incheon, Republic of Korea.
Jin Oh NaDivision of Cardiology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
Jinho ShinDivision of Cardiology, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
Kiho ParkMirabellsoft Co., Ltd., Seoul, Republic of Korea.
Eun Mi LeeDivision of Cardiology, Department of Internal Medicine, Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea. mdemlee@naver.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The implementation of Home Blood Pressure Monitoring (HBPM) has improved the diagnosis and treatment of hypertension. Current clinical guidelines advocate the use of validated HBPM devices. However, few studies have examined the current use of validated HBPM devices. We aimed to investigate the current status of the use of validated HBPM devices in real-world hypertensive patients. This study was conducted on Korean patients with hypertension using CareforMe®, a smartphone healthcare application which allows the patients to record their HBPM data which can be shared with their physicians. The validation status of HBPM devices was identified based on four registries: STRIDE BP, Medaval, the Japanese Society of Hypertension, and dabl® Educational Trust. From January 2022 through August 2024, 2731 patients entered the model numbers of their HBPM devices. 56.4% (n = 1539) of the population were male, and the mean age was 53.5 ± 10.8 years old. 110 models from 33 different manufacturers were identified. 97.0% (n = 2649) of the patients used upper-arm devices and 3.0% (n = 82) used wrist devices. Based on the four registries, 32.7% (n = 36) out of 110 devices were validated, and 51.5% (n = 1407) out of 2731 patients used validated devices. Patients using validated devices tend to use more expensive devices than those using non-validated devices (P < 0.0001). Among Korean patients with hypertension undergoing HBPM, 97.0% of the patients used upper-arm devices and 51.5% of the patients used validated devices. Our results proposed the urgent need for patient education and public accessibility to validated devices for the better management of patients with hypertension. The validation status of HBPM devices was identified based on four registries: STRIDE BP, Medaval, the JSH, and dabl® Educational Trust. 51.5% (n = 1,407) out of 2,731 patients used validated devices and 32.7% (n = 36) out of 110 devices were validated. Patient education and public accessibility on validated devices are urgently needed. HBPM home blood pressure monitoring; JSH Japanese Society of Hypertension.

Indexed as

Blood Pressure Monitoring, AmbulatoryHypertensionAdultAgedFemaleHumansMaleMiddle AgedRepublic of KoreaBlood Pressure MonitorsHome Blood Pressure MonitoringHypertensionImplemental HypertensionValidated devices

Identifiers

PMID40903536
PMCPMC12586138

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.